Congress Materials – Maui Derm Caribbean 2026
2026 Maui Derm Caribbean | Jan 7-10 | San Juan, Puerto Rico
This section includes selected Johnson & Johnson Innovative Medicine abstracts, posters, or oral presentations, which have been accepted for congress presentations in the last 2 years or less (as determined by any congress restrictions on length of time materials can be posted). Information about pipeline products or investigational uses of products does not imply FDA approval for these products or uses, nor does it establish the safety or efficacy of these products or uses. Johnson & Johnson does not recommend or suggest use of its medicines in a manner inconsistent with FDA-approved labeling. The content contained in this section is subject to congress copyright permissions.
Durability of Response to the Targeted Oral Peptide Icotrokinra for High-Impact Site Psoriasis: 1-Year ICONIC-TOTAL Findings
Edward Lain, Richard B. Warren, Melinda Gooderham, Robert Bissonnette, Yu-Huei Huang, Julien Ringuet, Matthias Hoffmann, Andreas Pinter, Joseph F. Merola, Jessica H. Rubens, Dorothy Fan, Ming-Chun Hsu, Shu Li, Ya-Wen Yang, Cynthia DeKlotz, Eingun James Song
Durable Inhibition of Structural Damage Progression and Improvements in Joint Disease Activity With Guselkumab in Active and Erosive Psoriatic Arthritis: Week 48 Results From APEX
Christopher T. Ritchlin, Philip. J Mease, Laura C. Coates, Alexa P. Kollmeier, Bei Zhou, Yusang Jiang, Karen Bensley, Koeun Im, Rattandeep Batra, Karissa Lozenski, Steven Fakharzadeh, Soumya D. Chakravarty, Proton Rahman, Désirée van der Heijde
Unmet Needs and Disease Burden: Perspectives from Adults with Psoriasis and Clinicians treating Psoriasis in the United States
Linda Stein Gold, Jennifer Soung, Nina Trenkler, Melina Taylor, Laurie Conklin, Jensen Lewis, Timothy Fitzgerald, Wesley Peters, Ya-Wen Yang, Guo Li, Mona Shahriari
Copies of these presentations are for personal use only and may not be reproduced without written permission from the presentation author.